Dixon Hughes Goodman Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$87K Buy
303
+103
+52% +$26.5K 0.03% 260
2021
Q4
$55K Buy
+200
New +$50.7K 0.02% 255

Other funds holding LLY

Dixon Hughes Goodman Wealth Advisors's LLY Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its Eli Lilly (LLY) stake by 52% in Q1 2022, buying an estimated $26.5K and bringing the position to 303 shares worth $87K. The position accounts for 0.03% of the portfolio, ranked #260.

Dixon Hughes Goodman Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 2 quarters since. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 303 shares of Eli Lilly worth $87K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors bought 103 Eli Lilly shares in Q1 2022, an estimated $26.5K.
  • Eli Lilly made up 0.03% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #260 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 2 quarters since.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.